PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.70%
Both yoy net incomes decline, with AVGO at -22.09%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5.08%
Some D&A expansion while AVGO is negative at -1.72%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-171.15%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
18.18%
SBC growth well above AVGO's 9.09%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-214.16%
Negative yoy working capital usage while AVGO is 145.71%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-146.86%
AR is negative yoy while AVGO is 279.25%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
440.00%
Inventory growth of 440.00% while AVGO is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-1000.00%
Both negative yoy AP, with AVGO at -366.67%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-1161.54%
Both reduce yoy usage, with AVGO at -640.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
117.19%
Well above AVGO's 75.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-61.47%
Negative yoy CFO while AVGO is 8.02%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
28.04%
CapEx growth well above AVGO's 8.77%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Negative yoy acquisition while AVGO stands at 100.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-43.97%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
14.60%
We have some liquidation growth while AVGO is negative at -100.00%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
148.72%
Growth well above AVGO's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-147.97%
We reduce yoy invests while AVGO stands at 3.70%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
68.45%
We slightly raise equity while AVGO is negative at -53.66%. John Neff sees competitor possibly preserving share count or buying back shares.
1.91%
Buyback growth below 50% of AVGO's 63.64%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.